國立虎尾科技大學 |

Genetic influences on response to drug treatment for major psychiatric disorders

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Genetic influences on response to drug treatment for major psychiatric disorders/ edited by Janusz K. Rybakowski, Alessandro Serretti.
other author:	Rybakowski, Janusz K.
Published:	Cham :Springer International Publishing : : 2016.,
Description:	ix, 117 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Psychiatry - Alternative treatment. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-27040-1
ISBN:	9783319270401

Genetic influences on response to drug treatment for major psychiatric disorders
Genetic influences on response to drug treatment for major psychiatric disorders[electronic resource] /edited by Janusz K. Rybakowski, Alessandro Serretti. - Cham :Springer International Publishing :2016. - ix, 117 p. :ill., digital ;24 cm.

1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.

ISBN: 9783319270401

Standard No.: 10.1007/978-3-319-27040-1doiSubjects--Topical Terms:

1106223
Psychiatry
--Alternative treatment.

LC Class. No.: RC435

Dewey Class. No.: 616.89

Genetic influences on response to drug treatment for major psychiatric disorders
LDR:02417nam a2200313 a 4500 001 862708
003 DE-He213
005 20160819150241.0
006 m d
007 cr nn 008maaau
008 170720s2016 gw s 0 eng d
020 $a 9783319270401 $q (electronic bk.)
020 $a 9783319270388 $q (paper)
024 7 $a 10.1007/978-3-319-27040-1 $2 doi
035 $a 978-3-319-27040-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC435
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.89 $2 23
090 $a RC435 $b .G328 2016
245 0 0 $a Genetic influences on response to drug treatment for major psychiatric disorders $h [electronic resource] / $c edited by Janusz K. Rybakowski, Alessandro Serretti.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2016.
300 $a ix, 117 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.
520 $a Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.
650 0 $a Psychiatry $x Alternative treatment. $3 1106223
650 0 $a Nature and nurture. $3 566753
650 0 $a Genetics. $3 578972
650 0 $a Antipsychotic drugs. $3 863978
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Psychopharmacology. $3 644799
650 2 4 $a Human Genetics. $3 593893
700 1 $a Rybakowski, Janusz K. $3 1106221
700 1 $a Serretti, Alessandro. $3 1106222
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-27040-1
950 $a Medicine (Springer-11650)